Cis-platinum treatment of metastatic adrenal carcinoma.
Cis-platinum was used in the management of four patients with metastatic carcinoma of the adrenal cortex. In each instance, clinical and objective response was observed. This agent would appear to warrant further trial in the management of this rare tumour.
D000008:Abdominal Neoplasms / Q000556:secondary / Q000628:therapy; D000306:Adrenal Cortex Neoplasms / Q000188:drug therapy* / Q000556:secondary / Q000601:surgery; D000328:Adult; D002277:Carcinoma / Q000188:drug therapy* / Q000556:secondary / Q000601:surgery; D002945:Cisplatin / Q000627:therapeutic use*; D003480:Cushing Syndrome / Q000209:etiology; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000556:secondary / Q000628:therapy; D008297:Male; D008875:Middle Aged; D008939:Mitotane / Q000627:therapeutic use; D009362:Neoplasm Metastasis
D008939:Mitotane; D002945:Cisplatin